Respiratory Disease and Care

Cheepsattayakorn  graduated  Doctor  of  Medicine  from  Chiang  Mai  Medical  School, Chiang  Mai  University, Chiang  Mai, Thailand  in  1986.  He  then  further  had  trained  in  Internal  Medicine,   Pulmonology, and  Radiology  at  Chiang  Mai  University  Medical School.  Recently, on  October  26, 2019, he  was  bestowed  the  Gold  Medal  Award (First-Class  Award)  from  the  Chiang  Mai  University  Medical  School  Alumni  Association  in  Chiang  Mai, Thailand  for  his  academic  and  medical  practice  excellence  for  cerebrating  the  60th  Anniversary  of  the  Chiang  Mai  University  Medical  School, Chiang  Mai, Thailand  that  was  established  on  October  28, 1959.  He    graduated  numerous  Fellowships  from  the  Royal  Colleges  of  Physicians  of  Edinburgh, London  and  Thailand, Royal  College  of  Physicians  and  Surgeons  of  Glasgow, American  College  of  Physicians, and  American  College  of  Chest  Physicians.  Presently, he  serves  both  Editor  and  Editorial  Board  Member  and  also  referee  of  several  international  journals. 

  He  has  very  high  experience  in  the  fields  of  Pulmonary  Diseases  and  Tuberculosis  including  Infectious  Diseases  and  Immunology.  He  has  numerous  scientific  publications, more  than  300  publications  both  in  national  and  international  journals  and  books, including  authored  textbook  of  COVID-19, “ Thailand’s  and  Global  Perspectives  of  COVID-19 ”, both  the  United  Kingdom  version (361  pages, first  edition  published  by  the  Medical  and  Research  Publications  in  2021)  and  the  United  States  of  America  version (367  pages, second  edition  published  by  the  Science  and  Education  Publishing  in  2022).  He  had  been  served  as  Pulmonologist  and  Senior  Expert  Level  11 (Highest  Level-equivalent  to  Professor  of  Medicine  Level  11), Department  of  Disease  Control, Ministry  of  Public  Health, Thailand.  He  serves  as  Faculty  Member  of  the  Faculty  of  Medicine, Western  University, Thailand. 

Currently, he  also  serves  the  International  Regional  Adviser (Advisory  Board)  for  Thailand  of  the  Royal  College  of  Physicians  of  Edinburgh, United  Kingdom  and  the  Reviewer  for  the  journals  of  the  Royal  College  of  Physicians  of  London, United  Kingdom.   He  was  appointed  the  Japan  International  Cooperation  Agency (JICA)’s  Advisor  in  2021-2022.  He  was  directly  invited  &  proposed  to  the  World  Federation  of  United  Nations  Associations (WFUNA)  Membership  by  the  United  Nations  Former  Secretary-General  “ H.E.  Ban  Ki-Moon ”. Recently, he  has  been  approved  for  the  Membership  of  the  WFUNA  since  4  January  2022 (Ref. : UN-467-NYUN)  and  has  been  appointed  the  WFUNA  Membership  signed  by  the UN authorities (the  UN Secretary-General, the  UN President of the General  Assembly, and  the  UN  President  of  the  Security  Council)  since  January  15, 2022.

Sufana is a Lecturer in the Respiratory Care Department at Imam Abdulrahman bin Faisal University, Saudi Arabia. Master of Respiratory Medicine from the University of Birmingham, UK. Bachelor of Respiratory Care from AlMaarefa University, Saudi Arabia.

Manoj Nargund is a trained Pharmacologist {Doctor of Medicine (MD)} from University of Mumbai, India, & also holds a Diploma in Pharmaceutical Business Management. He has earlier served as Resident Medical Officer in internal medicine & ICU in prestigious public hospitals at Mumbai for 3 years; has been on teaching faculty for Pharmacology for medical & pharmacy graduates, & has 5 publications in peer-reviewed journals. As an Asia Pacific Medical Affairs & Clinical R&D professional in pharmaceutical industry for over 21 years, he has led key products in companies like Pfizer, Johnson & Johnson, Novartis, Zydus Cadila, Macleods, Abbott, & GSK, in multiple therapy areas, including in Respiratory & Infectious Diseases, to address unmet therapeutic needs of patients with asthma, COPD, ILD/IPF, PAH, & in various bacterial & fungal respiratory infections. Some of his key achievements in these areas include, introduction of doxofylline, montelukast & deflazacort for asthma/COPD as per GINA/GOLD guidelines; introduction of 3rd/4th generation beta-lactams & fluoroquinolones; & implementation of various digital/non-digital medical education intiatives for physicians & patients. He is passionate about learning & implementing strategies for addressing the challenges of sub-optimal control of asthma & COPD, & increasing anti-microbial resistance (AMR)

Sadia Saber, currently working as an Assistant Professor in the department of Medicine, Bangladesh Medical College, Dhanmondi, Dhaka, Bangladesh for the last 4 years. She has completed her MBBS under the university of Dhaka in the year July 2010 with honours marks in Anatomy, Physiology, Biochemistry and Pathology. She also secured 4^th position in the merit list during her 2^nd Professional MBBS Examination.Then she completed her 5 years Post-graduation Clinical Training at Bangladesh Medical College Hospital From January 2012 – December 2016. She has acquired her Fellowship (FCPS) in Internal Medicine from Bangladesh College of Physicians and Surgeons (BCPS) in the session of January 2017. She has obtained her MRCP (UK) & MRCP (Ireland) in the year of November 2017 & October 2019 respectively. She has passed MRCP SCE in Respiratory Medicine (UK) in the year of October 2021. She has also completed her Postgraduate Diploma in Respiratory Medicine, under the University of South Wales, Cardiff (UK) in the session of 2021-2022.She has acquired European Diploma on Respiratory Medicine (Switzerland) on 2022. Currently she is doing her Master’s Degree in Sleep Medicine under the European University of Madrid, Madrid, Spain. She is working as an active member of the Royal College of Physicians and Surgeons of Glasgow (UK), the Royal College of Physicians of Edinburgh (UK), American College of Physicians (USA) & American College of Chest Physician (USA). She has got more than 35 publications in both national and international level, among those she is the 1^st author for than 25 publications.

Gediminas “Gedi” Mainelis is a Professor in the Department of Environmental Sciences at Rutgers, the State University of New Jersey, USA. He has a Bachelor’s degree in physics from Vilnius University, Lithuania, and a Ph.D. in Environmental Health from the University of Cincinnati, Ohio, USA. His research focuses on various aspects of bioaerosol science, including sampling and analysis methods, exposure assessment, and airborne microbiomes. Over the past years, his research expanded to investigate exposures to manufactured nanoparticles and explore indoor air issues. Several of his current projects focus on COVID-19 issues. His research efforts have resulted in more than 110 peer-reviewed publications, book chapters, and several patents. In addition, multiple papers from his group have been included in the most downloaded article lists of various peer-reviewed journals. Dr. Mainelis has served as Chair of the Bioaerosols and Health-Related Aerosol working groups of the American Association for Aerosol Research (AAAR). He is currently an editor (associate) of the Aerosol and Air Quality Research journal. Prof. Mainelis is a recipient of the Research Excellence Award from Rutgers University and the Lyman A. Ripperton Environmental Educator Award presented by the A&WMA.

Grishma Desai is multifaceted Scientist and Quality Manager at Grignard Company LLC with experience in Biological Nutrient Removal (BNR), wastewater mineral removal and US EPA Pesticide Testing and Regulations. She has a Bachelor’s of Science in Biotechnology from Rutgers University, New Jersey, USA. During her eight years at Grignard Company, she has led multiple R&D efforts in new product development as well as regulatory compliance for products.  In the past two years, Ms. Desai’s work has focused on developing, testing and obtaining regulatory approvals for Grignard Pure® – an airborne antimicrobial effective against MS2 Bacteriophage, a surrogate for the SARS-CoV-2 as well as other bioaerosols. Ms. Desai worked closely with Dr Katherine Ratliff and her team at the US EPA Office of Research and Development to evaluate the efficacy of Grignard Pure® in reducing airborne virus concentrations using a large-scale test chamber and a standardized testing approach. Ms. Desai recently submitted a paper titled “The efficiency of Grignard Pure to inactivate airborne SARS-CoV-2 surrogate” to a peer reviewed journal detailing the testing conducted on Grignard Pure at independent testing labs.

M Lavae-Mokhtari is a consultant in the Respiratory Intensive Care Unit in General Hospital Ibbenburen in Germany since 2013. He has seven publications, 17 national and international poster publications, one book publication, and three scientific international and one national oral presentation. He has 152 citations and a 17.48 RG Score by research gate. He is a member of the German Respiratory Society, Section Intensive-Care and Ventilation Medicine, European Respiratory Society, Section Intensive-Care and Ventilation Medicine, and Section Thorax oncology and German Interdisciplinary Society of Outpatient Ventilation.

Nightingale Syabbalo is a Pulmonologist, and Clinical Respiratory Physiologist by training, and obtained his postgraduate training at St. George’s Hospital Medical School, University of London, UK. He was trained by one of the international distinguished Respirologists of our times. Nightingale has worked as an academician, Consultant Physician, and Clinical Researcher in several counties, including Canada, Kuwait, Oman, South Africa, and Zambia. He has published extensively in high-impact medical journals, and is an Editorial Board member of twenty-two journals in Pulmonology and Respiratory Medicine; and a reviewer of four journals in Thoracic Medicine, Respiratory Research, and Internal Medicine. Prof. Syabbalo’s current area of research focuses on the role of interleukins in the pathophysiology and treatment of severe asthma. He has also interested in the mechanisms of interleukins-1β in the pathogenesis and treatment of pericardial syndromes.

Scientist and Clinician, NHS physician at the Royal Papworth Hospital Cambridge, discoverer of first effective therapies for Pulmonary Arterial Hypertension [PAH] (iv. Prostacyclin and Inhaled NO). Established the UK National Network of PAH centres. Professor, Medicine Sheffield University Medical School and Senior Principal Scientist AstraZeneca plc, Corporate Clinical Director Chiesi Farmaceutici (Italy), Architect of the first triple inhaler for asthma/COPD Trimbow®, Senior Partner TranScrip LLP, R&D Director Allergy Therapeutics plc, Vice President, and President Faculty of Pharmaceutical Medicine Royal Colleges of Medicine UK. CEO and founder of Camcon Robotics Ltd.

Jack Caravanos, life in the field ranges from jumping onto a motorcycle and navigating the jungles of Madre de Dios in the Peruvian Amazon studying toxic substances to traveling to remotes areas in Zambia, Indonesia, and Bolivia studying lead and other toxic wastes. By cooperating with local governments, his work provides safe, healthy, and evidence-based solutions for pollution problems in low- and middle-income countries. In partnership with Pure Earth, an international non-profit organization, Caravanos is studying the impact of gold extraction with mercury in Peru and Indonesia. Since miners are in danger of mercury poisoning, his research team is planning interventions that teach safer techniques for gold extraction. In Kabwe, Zambia - a mining town with exposure to lead - his research will provide methods to institute safer mining practices and policy recommendations to improve environmental remediation laws. Caravanos teaches Environmental Health for graduate students and Environmental Health in a Global World for undergraduate students. He also provides opportunities for student researchers in his ongoing projects, including in Indonesia and Ghana.

Mitch Simpler joined JB&B, a global consulting engineering firm, in 1977 and currently serves as a partner after having served as Managing Partner from 2012- 2018. He has acted as project manager and partner-in-charge on life/health science institutions, health care facilities, high-rise office buildings, museums, residential and mixed-use buildings, as well as hotels. Simpler’s list of notable projects in the life science sector spans the past 45 years, including premier laboratory facilities and research centers in New York City, such as the Jerome L. Greene Science Center at the Columbia University Manhattanville campus, The East River Science Park in New York, the New York Genome Center, Mount Sinai’s Hess Center for Science and Medicine, Weill Cornell Medical College’s Belfer Research Building, MSK’s David H. Koch Center for Cancer Care and Rockefeller Research Laboratories, Cornell University’s Biotechnology Building, and NYU Langone Health’s Smilow Research Building and Skirball Institute of Biomolecular Medicine. His experience extends around the world to China, with the Innovation Center at Duke Kunshan University in Kunshan and the Rohm & Haas Research Center in Shanghai. Mr. Simpler is a fellow of the American Council of Engineering Companies (ACEC) and recently served as the National Chairman of ACEC. He is also a founding member and Co-Founder of NYC Builds Bio+.

Rivkees is a Professor of the Practice of Health Services, Policy, and Practice in the School of Public Health. He served as Florida's State Surgeon General and Secretary of Health from 2019 to 2021. Before moving to Florida, he served as a professor of pediatrics with tenure at Yale University. Dr. Rivkees has had more than 35 years of continuous research funding from the National Institutes of Health. He was responsible for the safety alert on liver toxicity caused by the antithyroid drug propylthiouracil. This led to major international treatment practice changes.

Verin completed his Ph.D. at the age of 29 years from Moscow State University, Moscow, USSR, and postdoctoral studies at the University of Indiana. During his scientific carrier, he was a faculty member at Johns Hopkins and the University of Chicago. Currently, he is a Professor at the Vascular Biology Center and Pulmonary Division, School of Medicine, Medical College of Georgia, at Augusta University, Augusta, GA.   He has published more than 170 papers in reputed journals primarily in the field of pulmonary vascular endothelial barrier regulation.  He served as an Editorial board member of the American Journal of Physiology (Lung) from 2006-2011 and Editor-in-chief of the academic journal, Vessel Plus, in 2016-2022. He is currently serving as an academic editor of the British Journal of Medicine and Medical Research and Cardiology and Angiology, and an editorial board member in several other journals in the field of pulmonary/cardiovascular research such as Biomolecules, Cardiovascular Pharmacology, Journal of Multidisciplinary Pathology, Tissue Barriers, World Journal of Respirology.

Iveta Madzharova is a biologist at the National Center for Infectious and Parasitic Diseases, National Laboratory "Influenza and SARS", Sofia, Bulgaria since the beginning of 2022. She has а bachelor’s degree in Biotechnology - Sofia University "St. Kliment Ohridski", Biological Faculty and started a master's degree in 2021 in the field of Microbiology and microbiological control - Sofia University "St. Kliment Ohridski", Biological Faculty. She is developing a master's thesis on the research topic. She participated in two projects related to the research topic. She published one article with impact factor in a reputable journal on the topic "Clinical significance and role of co-infections with respiratory pathogens among individuals with confirmed coronavirus-2 infection with severe acute respiratory syndrome". She participated in an international congress.

Brian T. Regan serves as Chief Strategy Officer for Grignard Pure, LLC, an innovative science and technology company developing next-generation solutions for eliminating airborne pathogens in all indoor environments from healthcare, to food processing, to workplaces, schools, and homes. He is responsible for shaping and executing Grignard Pure’s go-to-market strategy, integrating science, IP, regulatory, product development and partner engagement into successful implementation. Prior to joining Grignard Pure in January 2021, he spent twenty-five years working with organizations from start-ups to Fortune 500 companies, helping position them for optimal competitiveness in the markets they serve. Among those companies he counseled include Virgin, EMC, CA Technologies, Intuit, MongoDB, Docusign, and Philips.

Martha is a registered EHP with the Health Professions Council of South Africa. She is a holder of a Bachelor of Science Degree in Environmental Health. She also have an MBA in Environmental and Energy Management from Twente University. She completed an Honors in Leadership at the University of Johannesburg. She is currently registered for a PhD in Public Health at Witwatersrand University focusing on Occupational Health injuries. She was involved in the creation and content development on the online Master of Public Health at the University of Johannesburg. Currently she is an Online Facilitator on the Sample Abstract Template Master of Public Health at the University of Johannesburg. She has been an Adjunct lecturer at the Witwatersrand University and MANCOSA for more than three years. She has published papers on occupational and environmental health in internationally accredited journals. She has supervised more than 16 Masters Students to completion in her career. Her niche area of research is occupational and environmental health. She also involved with research that is focusing on how artificial intelligence is impacting occupational and environmental health. She was recently recognized as one of the top fifty influential women in Science, Technology, Engineering, and Mathematics (STEM) in South Africa for her contribution in the subject matter.